HepGene, Inc.
Biotechnology company · Fairfield, Connecticut, United States
HepGene, Inc. is a biotechnology company headquartered in Fairfield, Connecticut, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $25,208 sold in a notice filed in 2020.
HepGene at a glance
What does HepGene do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $25,208 sold (2020).
Frequently asked questions about HepGene
Where is HepGene headquartered?
HepGene, Inc. is headquartered in Fairfield, Connecticut, United States.
What does HepGene do?
HepGene, Inc. is a biotechnology company.
When was HepGene founded?
The earliest incorporation on record for HepGene, Inc. is in 2020, according to public company registers.
Similar companies
- Liquid Lung DX, Inc.Fairfield, Connecticut, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences